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ABSTRACT The marine guanidinium toxins, saxitoxin (STX) and tetrodotoxin (TTX), have played crucial roles in the study of
voltage-gated Na channels. Because they have similar actions, sizes, and functional groups, they have been thought to
associate with the channel in the same manner, and early mutational studies supported this idea. Recent experiments by
Kirsch et al. (1994. Biophys. J. 67:2305–2315) have suggested that the toxins bind differently to the isoform-specific domain
I Phe/Tyr/Cys location. In the adult skeletal muscle Na channel isoform (I), we compared the effects on both TTX and STX
affinities of mutations in eight positions known to influence toxin binding. The results permitted the assignment of energies
contributed by each amino acid to the binding reaction. For neutralizing mutations of Asp400, Glu755, and Lys1237, all thought
to be part of the selectivity filter of the channel, the loss of binding energy was identical for the two toxins. However, the loss
of binding energy was quite different for vestibule residues considered to be more superficial. Specifically, STX affinity was
reduced much more by neutralizations of Glu758 and Asp1532. On the other hand, mutation of Tyr401 to Cys reduced TTX
binding energy twice as much as it reduced STX binding energy. Kinetic analysis suggested that all outer vestibule residues
tested interacted with both toxins early in the binding reaction (consistent with larger changes in the binding than unbinding
rates) before the transition state and formation of the final bound complex. We propose a revised model of TTX and STX
binding in the Na channel outer vestibule in which the toxins have similar interactions at the selectivity filter, TTX has a
stronger interaction with Tyr401, and STX interacts more strongly with the more extracellular residues.
INTRODUCTION
The marine guanidinium toxins tetrodotoxin (TTX) and
saxitoxin (STX) are specific high-affinity blocking ligands
of voltage-dependent Na channels. They have been invalu-
able in biochemical purification of the channels (Catterall,
1995), in pharmacological characterization of the different
channel isoforms (Moczydlowski et al., 1986a), and in
determination of the channel density in cells (Ritchie and
Rogart, 1977). These toxins bind competitively to a site on
the external surface of the channel, named toxin site 1
(Catterall, 1980, 1986, 1988). Terlau et al. (1991) have
located this site to the SS1-SS2 segments of all four do-
mains of the channel protein by demonstrating that several
mutations in this region of the rat brain II Na channel
isoform altered binding affinities of STX and TTX. Further-
more, some of their mutants changed permeation and/or
selectivity of the channel, leading Terlau et al. (1991) to
propose an alignment of portions of the four segments
(pore-forming or P loops), one from each of the four do-
mains, that form the channel outer vestibule and toxin site 1.
According to their alignment of the four P loops, an inner
set of the residues Asp, Glu, Lys, and Ala (DEKA) formed
the narrowest part of the pore and functioned as the selec-
tivity filter. A more superficial or extracellular set of aligned
residues was composed of Glu, Glu, Met, and Asp from
domains I–IV, respectively. Subsequently, residues of both
sets have been implicated in channel conductance, selectiv-
ity, or toxin binding (Noda et al., 1989; Terlau et al., 1991;
Backx et al., 1992; L.-Q. Chen et al., 1992; Heinemann et
al., 1992b; Kontis and Goldin, 1993; Stephan et al., 1994;
Chiamvimonvat et al., 1996a,b; Favre et al., 1996; Pe´rez-
Garcı´a et al., 1996, 1997; Schlief et al., 1996; S. F. Chen et
al., 1997; Sun et al., 1997; Tsushima et al., 1997).
TTX and STX are thought to bind to the channel in the
same manner (Hille, 1975; Kao and Walker, 1982; Stri-
chartz, 1984; Kao, 1986; Yang et al., 1992). This idea is
based upon the fact that the two toxins completely block
current, competitively inhibit each other in binding assays,
are of similar size, and possess similar functional groups,
including one or two guanidinium groups and a diol that are
thought to be critically important for binding of either toxin.
Furthermore, both toxins appear to block at the same depth
within the electric field when the greater charge of STX is
taken into account (Satin et al., 1994b), and mutations in the
outer vestibule seem to have qualitatively similar effects on
the affinities of both toxins (Noda et al., 1989; Terlau et al.,
1991; Kontis and Goldin, 1993; Stephan et al., 1994). These
similarities led Lipkind and Fozzard (1994) to propose a
specific molecular model of the TTX and STX binding site
based upon one guanidinium group of each toxin binding to
the selectivity region in an identical manner.
The idea that STX and TTX bind in the same manner is
reinforced by experiments suggesting that a single site in the
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domain I pore-forming region is responsible for the known
isoform differences in STX and TTX affinities (Backx et al.,
1992; L.-Q. Chen et al., 1992; Heinemann et al., 1992a;
Satin et al., 1992, 1994a; Kirsch et al., 1994; Favre et al.,
1995; Pe´rez-Garcı´a et al., 1996). STX and TTX bind to
cardiac Na channels with an 25–100-fold lower affinity
than to nerve or skeletal muscle channels. The lower affinity
for both toxins in the cardiac isoform is thought to be the
result of a Cys for Phe or Tyr substitution in domain I of the
outer vestibule, which gives the cardiac Na channel its
distinctive phenotype of a reduced sensitivity to STX and
TTX and an increased sensitivity to group IIb metals and
Ca2. This difference in TTX affinity was reproduced in the
Lipkind-Fozzard model (Lipkind and Fozzard, 1994) when
an aromatic residue was substituted for Cys and TTX affin-
ity increased by 4–5 kcal/mol.
Recently the hypothesis that STX and TTX bind in the
same manner has been challenged by Kirsch et al. (1994),
who demonstrated that the sulfhydryl reagent (2-amino-
ethyl)methanethiosulfonate (MTSEA) could decrease con-
duction of the human cardiac Na channel (hH1a) by for-
mation of a disulfide bond with the Cys in domain I of the
pore. When bound to the channel, TTX protected Cys373 of
hH1a from reaction with MTSEA, but STX did not, imply-
ing different binding arrangements for TTX and STX, at
least for the region surrounding the Cys residue. In addition,
Kontis and Goldin (1993) found that mutation of the outer
ring glutamate of domain II in the rat brain IIA isoform had
a larger effect on STX binding than on TTX binding. To
determine differences in the specific interactions between
the channel vestibule and the toxins, a quantitative compar-
ison under identical conditions of the effects of mutations
on both toxins is necessary. If they are bound in the same
manner, then each mutation should produce an equivalent
affinity change for both toxins. We studied the effects on
TTX and STX affinities of mutations at eight important
vestibule sites in the skeletal muscle Na channel -subunit
(I) expressed in Xenopus oocytes. To consider the mech-
anisms of differences in mutation effects and as a check on
the IC50 measurements, we also measured the time courses
of onset and offset of block.
A clear pattern emerged from these studies. First, the
changes in binding energy (G) for TTX and STX were
almost identical for mutations of Asp400, Glu755, and
Lys1237, the tested residues from the selectivity region. The
largest G was for E755A of 5.4–5.7 kcal/mol. We con-
cluded that the two toxins bind in a similar way to the
selectivity region, and this was probably the mechanism of
their block. Second, the effects of mutations of the more
superficial set of charged residues were markedly different
for TTX and STX. They showed the same change in energy
when Glu403 was neutralized (G  5.2–6.2 kcal/mol), but
the binding energy changes with mutations of Glu758 and
Asp1532 were twice as large for STX (G  6.0–6.2 kcal/
mol) as for TTX (G  2.4–3.3 kcal/mol). This suggested
that a functional group not present in TTX, probably the
second guanidinium of STX, interacted with the channel at
this more extracellular location. Finally, mutation of Tyr401
to Cys caused twice the loss of binding energy for TTX than
for STX (4.8 versus 2.7 kcal/mol). Based on these experi-
mental data, adjustments in the positions of TTX and STX
within the previously published outer vestibule model were
able to explain many of these experimental findings, includ-
ing access of MTSEA to Cys401 in the presence of STX.
MATERIALS AND METHODS
Oligonucleotide-directed point mutations were introduced by one of the
following methods: mutations D400A, Y401D, Y401C, M1240K, and
M1240E by the Unique Site Elimination Mutagenesis Kit (Pharmacia
Biotech, Piscataway, NJ), following the manufacturer’s instructions; mu-
tation E403Q by the Altered Sites System (Promega, Madison, WI),
following the manufacturer’s instructions; mutation E755A by two primer
PCR; mutations K1237R and K1237A by three primer PCR (Bowman et
al., 1990); and mutations D1532N and E758Q by four primer PCR (Higu-
chi, 1990). Oligonucleotides were designed with silent restriction site
changes for rapid identification of mutants. Vectors consisting of either the
adult rat skeletal muscle Na channel (I) coding sequence flanked by
Xenopus globin 5 and 3 untranslated regions in the pAlter phagemid
(Promega, Madison, WI) or subcloned portions of this construct were used
as templates for mutagenesis. PCR fragments were isolated and subcloned
into I by using directional ligations. The presence of the intended muta-
tions and the absence of inadvertent mutations were verified by DNA
sequencing of the entire polymerized regions. The vectors were linearized
by SalI digestion and transcribed with SP6 DNA-dependent RNA poly-
merase, using reagents from the mCAP RNA Capping Kit (Stratagene, La
Jolla, CA). The I construct was a gift from Dr. Randall Moorman. The
human heart Na channel (hH1a) was obtained as a gift from Dr. Hali
Hartmann, linearized with HindIII, and transcribed with T7 DNA-depen-
dent RNA polymerase in the same manner as for I. All PCR reagents
were obtained from Perkin-Elmer (Norwalk, CT), and all restriction endo-
nucleases were purchased from New England Biolabs (Beverly, MA).
Stage V and VI Xenopus oocytes from female frogs (NASCO, Ft.
Atkinson, WI) were isolated and washed with a solution consisting of 90
mM NaCl, 2.5 mM KCl, 1 mM MgCl2, 1 mM NaH2PO4, and 5 mM
HEPES, titrated to pH 7.6 with 1 N NaOH, treated with 2 mg/ml collage-
nase (Sigma, St. Louis, MO) for 1.5 h, and had their follicular layers
removed manually. Using a Drummond microinjector (Broomall, PA),
50–100 ng of cRNA was injected into each oocyte. Oocytes were
incubated at 16°C for 12–72 h before examination in a solution consisting
of 90 mM NaCl, 2.5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 1 mM
NaH2PO4, 2.5 mM Na pyruvate, 100 g/ml gentamicin (Gibco-BRL,
Grand Island, NY), 50 U/ml nystatin (Sigma), and 5 mM HEPES titrated
to pH 7.6 with 1 N NaOH.
Recordings were made in the two-electrode voltage-clamp configura-
tion, using a Dagan CA-1 voltage clamp (Minneapolis, MN). Data were
collected using pClamp6.3 software (Axon Instruments, Foster City, CA)
at 71.4 kHz after low-pass filtration at 2 kHz (8 pole Bessel, 3 dB),
except for recordings of the more rapidly gating hH1a that were low-pass
filtered at 10 kHz. All recordings were obtained at room temperature
(20–22°C). Electrodes were filled with 3 M KCl and had resistances
between 0.3 and 0.6 M. The bath was constructed to favor laminar flow,
and oocytes were placed in the middle of the bath flow to ensure rapid and
uniform changes in the toxin concentration in the vicinity of the oocyte.
Bath flow was typically 500 l/min. The bath solution exchange rate was
estimated by determining the time course of change in peak INa for oocytes
expressing hH1a with voltage steps at 5-s intervals during a change from
90 mM NaCl to 45 mM NaCl and back. The time courses of INa changes
were well fitted by single exponentials with time constants of 15–18 s.
Examples of recordings of the peak Na currents during wash in and wash
out of toxin are shown in Fig. 1. For the different mutations, the time
constants of the onset of and the recovery from toxin block ranged from 35
to 101 s and 47 to 177 s, respectively. In control experiments, the time
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constants were not changed by doubling the solution flow rate. The effect
of the bath exchange rate on the measured toxin blocking rate constants
was calculated to result in a maximum error of less than twofold.
The standard bath solution consisted of 90 mM NaCl, 2.5 mM KCl, 1
mM CaCl2, 1 mM MgCl2, and 5 mM HEPES titrated to pH 7.2 with 1 N
NaOH. Recordings made with K1237A used 1 mM BaCl2 in place of
CaCl2, because mutation of this residue rendered the channel permeable to
Ca2 (Heinemann et al., 1992b; Favre et al., 1996; Schlief et al., 1996;
S. F. Chen et al., 1997; Pe´rez-Garcı´a et al., 1997; Sun et al., 1997;
Tsushima et al., 1997), and upon channel activation in the presence of
Ca2, a large outward current was induced. Control experiments in Ba2-
containing solution with oocytes expressing wild-type I showed no sig-
nificant change in the equilibrium binding or kinetics measured under these
conditions. STX and TTX were obtained from Calbiochem (La Jolla, CA).
STX is shipped as a 1 mM stock solution in 100 mM acetic acid. Stock
solutions of 3 mM TTX solution were made by diluting with distilled
water. Stocks were stored at 20°C. Stored in this manner, toxin stock
solutions showed no degradation over the course of these experiments.
Toxin solutions of the desired concentrations were made by adding toxin
stock solution to the standard bath solution and adjusting the pH to 7.2 with
1 N NaOH, as necessary.
The effect of toxin addition was monitored by recording the peak
current elicited every 20 s upon step pulses to20 mV,10 mV, or 0 mV
of 70 ms duration for hH1a, K1237A, and all other mutations, respectively.
The holding potential was100 mV, except in the case of hH1a, where the
holding potential was adjusted to 120 mV to ensure full channel avail-
ability. With this protocol, the time course to complete equilibration with
the toxin was observed, and the 20-s interpulse interval avoided the
development of use-dependent toxin block. The change in peak current
with time was well fitted by single-exponential functions for all combina-
tions of toxins and channels. Fitting was performed using the simplex
algorithm provided with the pClamp6.3 software. The IC50 for toxin
binding was calculated from the ratio of peak currents in the absence and
presence of toxin based on a single-site Langmuir absorption isotherm
according to the formula IC50  [toxin](Itoxin/Imax)/(1  (Itoxin/Imax)),
where Itoxin is the equilibrium peak current in the presence of a given toxin
concentration and Imax is the peak current under control conditions. The
inverse of the time constant of toxin unbinding (off) was taken as the rate
constant, koff. The pseudo-first-order rate constant, kon, was calculated from
the time constant of the decrease in peak current during association of the
toxin (on) by using the following formula: kon 1/[toxin]*(1/on 1/off).
A kinetically derived toxin dissociation constant was calculated (Kd 
koff/kon) for comparison with the IC50. Occasionally, the onset and relief of
block did not follow an exponential time course, and those experiments
were not included in further analysis. In those experiments where both the
IC50s and Kds were calculated, they were found to be comparable. When
practical, a 50% inhibitory concentration of toxin was used to determine
the IC50. Only in cases in which the binding affinity was very low was it
necessary to decrease the toxin concentration to clearly resolve the expo-
nential time course for toxin binding.
Data are presented as means 	 SEM. Statistical comparisons were
performed using two-tailed Student’s t-tests or one-way ANOVAs. G was
calculated as the difference in the average RT ln(IC50) for the wild-type and
mutant channels (xy), where R is the gas constant and T is temperature.
The standard errors (SEs) for G were estimated as the sum of the standard
errors of the RT ln(IC50) averages. The standard error for the ratio of Gs
was determined by the formula
SE 

x/y2
SEx/x2 
SEy/y21/2.
Molecular modeling was performed with Biosym software (Biosym
Technologies, San Diego, CA), operating on a Silicon Graphics Elan 4000
workstation (Mountain View, CA). All energy calculations were based on
the Biosym consistent valence force field. Other details may be found in
Lipkind and Fozzard (1994).
RESULTS
Choice of mutations and control measurements
of Na current characteristics
For descriptive convenience, we will refer to the mutated
residues deep within the vestibule’s electric field (Chiam-
vimonvat et al., 1996a) as the “inner ring” and those located
more superficial as the “outer ring,” acknowledging that
residues in these “rings” originally proposed by Terlau et al.
(1991) may not be at exactly the same depth. Mutations
were carried out in these two rings and at position 401, the
site that confers phenotypic differences in guanidinium
toxin affinities. This residue is between these rings and will
be discussed separately.
The outer ring charged residues Glu403, Glu758, and
Asp1532 were neutralized by using the most conservative
substitutions. Inconsistencies in previous reports concerning
the importance of Met1240 in the outer ring of domain III to
TTX binding prompted further investigation of this site.
Previously in I, mutation of the Met1240 to Cys caused a
FIGURE 1 The method for determining the IC50 and kinetics of associ-
ation and dissociation between toxins and the channel. In this example, A
shows current traces recorded every 20 s at 0 mV from a holding potential
of 100 mV before and during application of 1 nM STX to native I Na
channels. The range on the ordinate has been adjusted to show that upon
application of STX the peak currents decrease in an exponential manner. B
shows the exponential recovery of the peak currents upon removal of STX.
In C, the peak current amplitude is plotted as a function of time. Applica-
tion of STX results in a time course of the decrease in the peak current that
is well fitted by a single exponential. The recovery of peak current is also
well fitted by a single exponential. The fitted exponential functions are
shown as solid lines through the data. The time constants of these expo-
nential functions can be used to calculate the toxin on and off rates as
described in the text. In this case, the IC50, Kd, kon, and koff are 3.6 nM, 7.3
nM, 2.48  106 M1 s1, and 1.81  102 s1, respectively.
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small but statistically significant improvement in TTX bind-
ing (Pe´rez-Garcı´a et al., 1996). However, Chen et al. (1997)
reported that the Cys substitution at this site in hH1a pro-
duced a 10-fold reduction in affinity for TTX and had no
effect on STX affinity, and the mutation of Met1240 to Gln
in the brain II isoform resulted in an 10-fold reduction in
STX and TTX binding (Terlau et al., 1991). In the studies of
Terlau et al. (1991), M1240K dramatically reduced affinity
for both toxins. To seek further insight into the role of this
residue in STX and TTX binding, Met1240 was mutated to
the positively charged Lys, which should electrostatically
reduce binding affinity for the positively charged toxin, and
to the negatively charged Glu, which would increase affinity
if the interactions were simply electrostatic in nature.
The charged residues located deeper in the vestibule that
are known to affect TTX and STX affinity are Asp400,
Glu755, and Lys1237. Terlau et al. (1991) found that, for
domains I and II, conservative substitutions led to drastic
reduction in single-channel conductance. Consequently, we
chose to replace them with Ala, which is known to result in
expressed whole-cell currents large enough to measure the
toxin effects accurately (Favre et al., 1996; Sun et al., 1997).
Finally, mutations of Tyr401, the position analogous to
Cys373 in hH1a, were undertaken to determine the nature of
the interactions between this site and the toxins. This inter-
action was probed with two mutations substituting Tyr401
with the neutral Cys or with the charged Asp. Both muta-
tions of I have been shown previously to affect binding of
one of the toxins (Backx et al., 1992; Favre et al., 1995;
Pe´rez-Garcı´a et al., 1996).
All mutants constructed and expressed in Xenopus oo-
cytes showed voltage-dependent inward currents typical for
Na channels. The reversal potentials for only K1237A
(2.6 	 5.9 mV) and E755A (33.6 	 0.7 mV) were signif-
icantly different from that in wild-type channels (45.5	 2.8
mV). Specifically, the reversal potential for the mutant
D1532N was not different from that of wild-type channels.
For K1237A, channel activation in Ca2-containing solu-
tions induced a large outward current that usually resulted in
the loss of voltage control. Substitution of Ba2 for Ca2
eliminated this outward current, so this current was pre-
sumed to be a Ca2-dependent Cl current induced by Ca2
influx through Na channels rendered nonselective by the
K1237A mutation, but this phenomenon was not studied
further.
Inner and outer ring residues significantly alter
TTX affinity
Table 1 compares the effects of inner and outer ring muta-
tions on the IC50, kon, and koff for TTX block. The ratios of
the IC50s for the mutant and native I channels are also
shown. The IC50 for TTX block of native I Na
 channels
in these experiments was similar to those reported for native
skeletal muscle preparations (Pappone, 1980; Moczyd-
lowski et al., 1984b; Guo et al., 1987) or for I expressed
heterologously in Xenopus oocytes (Trimmer et al., 1989;
Backx et al., 1992; L.-Q. Chen et al., 1992; Satin et al.,
1992; Stephan et al., 1994; Pe´rez-Garcı´a et al., 1996). The
calculated kon and koff were slower than those from native
Na channels reconstituted with batrachotoxin in lipid bi-
layers (French et al., 1984; Moczydlowski et al., 1984a,b,
1986b; Green et al., 1987; Guo et al., 1987), but were
similar to those from the frog node of Ranvier after account-
ing for a slight difference in the Kds of the two preparations
(Ulbricht et al., 1986). Possible reasons for this variation are
discussed later. Kd values calculated from the rate constants
agreed well with the IC50 measurements, however.
Glu755 of domain II was the most important of the inner
ring residues in determining the blocking efficacy of TTX.
The rank order of importance of the domains for the inner
ring residues was II  III  I. Neutralizations D400A,
E755A, and K1237A from domains I, II, and III resulted in
Gs of 3.3, 5.4, and 4.1 kcal/mol, respectively (see Table
4). These changes were associated primarily by decreases in
the toxin kons. Only in the case of E755A was there a
statistically distinguishable but small increase in the TTX
koff (p  0.026).
The relative importance of the domains was different for
the outer ring. Neutralizations in the outer ring showed the
rank order of the domains in blocking efficacy to be I 
II  IV, suggesting that Glu403 of domain I was of over-
riding importance to TTX affinity. E403Q showed the larg-
est G of 5.2 kcal/mol, with Gs of E758Q and D1532N
much smaller at 3.3 and 2.4 kcal/mol, respectively (see
Table 4). The koffs of all of the mutants were statistically
indistinguishable from each other or from the wild-type koff
(p  0.49, ANOVA). Therefore, changes in the IC50s when
these three residues were mutated were associated entirely
with decreases in kon.
TABLE 1 Changes in the IC50, kon, and koff for TTX observed with mutations of the inner and outer rings
Mutation Equilibrium IC50 (M) n kon (M
1 s1) n koff (s
1) n IC50 ratio
Native I 0.036	 0.006 10 3.53  105 	 5.66  104 9 1.02  102 	 1.82  103 9 1
D400A 6.0 	 0.7 7 2.93 102 	 9.15  101 3 1.26  102 	 8.21  104 3 168
E403Q 161 	 14 8 2.48 102 	 1.17  102 5 1.57  102 	 4.09  103 5 4521
E755A 229 	 21 6 2.90 102 	 8.12  101 6 2.69  102 	 5.41  103 6 6412
E758Q 6.2 	 0.3 8 4.86 103 	 1.01  103 4 1.47  102 	 3.46  103 4 174
K1237A 23 	 2 4 1.62 102 	 4.41  101 3 1.49  102 	 1.45  103 3 641
M1240E 87 	 5 7 4.15 102 	 1.23  102 6 1.98  102 	 2.88  103 6 2433
M1240K 238 	 17 5 1.02 102 	 2.09  101 3 1.58  102 	 4.82  103 3 6678
D1532N 1.5 	 0.2 19 6.14 103 	 2.40  103 8 1.45  102 	 2.54  103 10 43
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Both positively and negatively charged mutations at the
Met1240 significantly worsened TTX blocking efficacy.
M1240K resulted in a 5.4 kcal/mol G, whereas M1240E
resulted in a 4.8 kcal/mol change. As with the other muta-
tions, the main cause of the reduction in the IC50s with
either mutation was a decrease in kon.
Inner and outer ring residues also affect
STX affinity
The effects of inner and outer ring mutations on the IC50,
kon, and koff for STX are shown in Table 2. The IC50 for
STX block of native and heterologously expressed recom-
binant I Na channels was similar to that in previous
reports (Barchi and Weigele, 1979; Moczydlowski et al.,
1984b, 1986b; Guo et al., 1987; Satin et al., 1992; Stephan
et al., 1994; Favre et al., 1995). The blocking kinetics were
slower by a factor of 5 than those calculated from single-
channel recordings of STX block of skeletal muscle chan-
nels reconstituted in bilayers (Moczydlowski et al., 1984b;
Guo et al., 1987) and those reported by Favre et al. (1995)
for I expressed in Xenopus oocytes. The rate constants
differed by less than twofold from those reported for Na
channels of the node of Ranvier, however (Ulbricht et al.,
1986).
As seen for TTX, the inner ring mutations caused large
changes in affinity. E755A caused the largest change in the
IC50, implying that this residue was most important for STX
block efficacy. The rank order of importance of the domains
for STX block was II  III  I, and neutralizations with
Ala resulted in 5.7, 3.9, and 3.8 kcal/mol Gs for E755A,
K1237A and D400A, respectively (see Table 4). These
values are almost identical to the Gs for TTX blocking
caused by these three mutations. As in TTX, kinetic analysis
of STX showed that changes in the IC50s observed with Ala
substitutions resulted entirely from changes in the STX kons,
with no change in the toxin koffs. No statistically significant
changes in the koffs were observed with any of the mutations
in the inner or outer rings (p 0.10, ANOVA). As was seen
in TTX, the kons for STX were significantly reduced by
neutralizing the carboxyl groups Asp400 and Glu755, as
might be expected if these groups participated in electro-
static attraction of the toxin. Again, K1237A had the unex-
pected effect of decreasing the toxin kon implying that the
role of Lys1237 in toxin/channel association is not a simple
electrostatic attraction of the Lys for the divalent, cationic
STX. Supporting this assertion, K1237R appears to reduce
the IC50 by 144-fold, suggesting that Lys in this position is
crucial for optimum STX affinity (data not shown).
The outer ring amino acids played a more crucial role in
STX affinity than in TTX affinity. Domains I, II, and IV
appeared to be equally important for STX binding. For the
mutations E403Q, D1532N, and E758Q, Gs were 6.2, 6.2,
and 6.0 kcal/mol, respectively. These values were signifi-
cantly different from those seen with TTX. As was seen for
the inner ring, the loss of STX affinity was the result of
changes in the toxin kons without significant changes in the
koffs.
As in TTX, charged mutations at Met1240 caused large
changes in the IC50s for STX. With M1240K, the G was
6.1 kcal/mol. This result was qualitatively similar to the
effect of the analogous mutation in the rat brain II channel
(Terlau et al., 1991). The M1240E mutation resulted in a
loss of blocking efficacy (G  3.9 kcal/mol), but it was
considerably less than that seen with M1240K. Comparison
of the results of M1240K and M1240E leaves open the
possibility of an electrostatic component to the interaction
between Met1240 mutations and STX, but electrostatic con-
siderations were insufficient to explain the entire effect of
mutations at this site.
STX and TTX showed differences in their
response to mutations at Tyr401
In domain I, an additional site between the inner and outer
rings is important for STX and TTX binding (Backx et al.,
1992; L.-Q. Chen et al., 1992; Heinemann et al., 1992a;
Satin et al., 1992, 1994a; Kirsch et al., 1994; Favre et al.,
1995; Pe´rez-Garcı´a et al., 1996). We investigated whether
mutations at the Tyr401 site in I had similar effects on both
STX and TTX blocking kinetics and equilibrium affinity.
The results were compared with those obtained with the
human heart Na channel, hH1a, which normally contains
a Cys at this site.
Table 3 compares the IC50s and kinetic parameters of
TTX and STX blocking of the wild-type I, Y401D, Y401C
TABLE 2 Changes in the IC50, kon, and koff for STX observed with mutations of the inner and outer rings
Mutation Equilibrium IC50 (M) n kon (M
1 s1) n koff (s
1) n IC50 ratio
Native I 0.003 	 0.0004 10 5.13  106 	 3.06  106 4 1.34  102 	 1.74  103 4 1
D400A 1.9 	 0.2 10 1.60  103 	 3.65  102 7 1.02  102 	 1.46  103 7 627
E403Q 121 	 15 9 1.76  102 	 5.38  101 4 8.50  103 	 2.47  103 4 39292
E755A 55 	 5 8 8.63  102 	 3.21  102 4 1.84  102 	 3.34  103 4 17927
E758Q 89 	 10 5 4.26  102 	 8.51  101 3 1.09  102 	 4.94  103 3 29093
K1237A 2.8 	 0.7 6 3.68  103 	 1.81  103 4 2.16  102 	 5.50  103 4 902
M1240E 2.2 	 0.2 6 1.33  104 	 7.89  103 5 9.71  103 	 2.83  103 5 704
M1240K 103 	 15 10 2.25  102 	 4.12  101 4 1.75  102 	 5.20  103 4 33564
D1532N 117 	 15 9 1.68  102 	 8.24  101 4 1.49  102 	 2.60  103 4 38248
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and the human heart channels. As noted before, the blocking
efficacy of TTX was lower in the hH1a channel as com-
pared to I, and this was mainfested by differences in both
kon and koff. The IC50 for TTX block of hH1a was 40-fold
higher than that for I and was on the order of previously
reported values (Kirsch et al., 1994; Dumaine and Hart-
mann, 1996). Single-channel kinetics in batrachotoxin-mod-
ified channels showed qualitatively similar relationships of
the TTX binding to skeletal and heart muscle channels, with
a 30-fold difference in TTX blocking efficacy (Guo et al.,
1987).
The Y401C mutation of I did not reproduce the IC50
seen in hH1a, even though the mutation rendered all of the
amino acids between and including the inner and outer rings
the same as those in hH1a. Specifically, the IC50s for TTX
block of hH1a and I-Y401C were, respectively, 40- and
2250-fold greater than I. Backx et al. (1992) and Pe´rez-
Garcı´a et al. (1996) reported a similar difference in TTX
affinity between I-Y401C and the rat cardiac channel.
Moreover, the mutation of Phe to Cys in the analogous
position rendered the rat brain II Na channel insensitive to
10 M TTX (Heinemann et al., 1992a).
Favre et al. (1995) reported that Y401D bound STX more
strongly than Y401C. Therefore, it was anticipated that the
Y401D mutation might electrostatically attract TTX and
improve its blocking efficacy. This was not the case, how-
ever. The Y401D mutation resulted in a 5.2 kcal/mol G for
TTX, as compared to a 4.8 kcal/mol G with Y401C (see
Table 4). This difference suggested that there was an even
lower affinity for TTX when Asp was present in this posi-
tion than with the Cys substitution.
In contrast, mutations in the 401 position affected STX
blocking efficacy much less than that of TTX. As compared
with I, the IC50s for Y401C, Y401D, and hH1a were
reduced by 102-, 55-, and 48-fold, respectively. STX pre-
ferred the presence of a negatively charged residue to that of
Cys, and the IC50s for Y401C and hH1a were in much
closer agreement than those seen with TTX. The values for
IC50 were similar but slightly higher than those reported by
Favre et al. (1995). Furthermore, the findings agreed with a
Cys substitution in the rat brain II Na channel, where the
IC50 was 410 nM (Heinemann et al., 1992a). As is the case
with all of the outer vestibule mutations, the kons varied
considerably, but the koffs showed relatively less change.
Only the koff in the presence of Y401D was statistically
different from that of I (p  0.03).
DISCUSSION
We have compared the change in binding energy of TTX
and STX resulting from mutations of eight different sites in
the Na channel vestibule. This mutational analysis permit-
ted testing of a model we had previously proposed for
guanidinium toxin binding to the outer vestibule (Lipkind
and Fozzard, 1994), which had been challenged by muta-
tional (Kontis and Goldin, 1993) and channel modification
studies (Kirsch et al., 1994). We found that mutations of the
three charged residues in the inner ring DEKA motif asso-
ciated with the selectivity region of the pore led to identical
changes in binding of both TTX and STX. In contrast,
mutations of more superficial residues showed substantial
differences in their effects on binding of the two toxins. The
isoform-specific residue at position 401 (Phe/Tyr/Cys) also
showed different roles in toxin binding. This new informa-
tion supports our general scheme for the guanidinium toxin
binding site but necessitates changes in several aspects our
original model. Furthermore, it demonstrates that the iso-
form amino acid differences at positions analogous to 401
are not sufficient to explain fully the channel phenotypic
differences in toxin affinities.
TABLE 3 Comparison of IC50s and kinetic parameters in I, Tyr
401 mutants, and hH1a channels
Equilibrium IC50 (M) n kon (M
1 s1) n koff (s
1) n IC50 ratio
TTX
Native I 0.036 	 0.006 10 3.53  105 	 5.66  104 9 1.02  102 	 1.82  103 9 1
Y401D 171 	 15 9 3.03  102 	 2.49  102 3 1.42  102 	 5.36  103 3 4800
Y401C 80 	 15 6 8.77  102 	 2.29  102 4 2.60  102 	 7.54  104 4 2249
hH1a 1.5 	 0.2 4 4.41  103 	 8.61  102 4 2.11  102 	 7.49  104 4 41
STX
Native I 3.1 	 0.4 10 5.13  106 	 3.06  106 4 1.34  102 	 1.74  103 4 1
Y401D 169 	 14 10 2.41  104 	 6.23  103 6 7.10  103 	 5.14  104 6 55
Y401C 314 	 12 5 6.51  104 	 1.43  104 4 2.18  102 	 3.44  103 4 102
hH1a 149 	 18 6 9.50  104 	 4.35  104 5 9.09  103 	 5.19  104 5 48
TABLE 4 Changes in equilibrium binding free energy of STX
and TTX for the outer vestibule mutants
Mutation GSTX 	 SE GTTX 	 SE GSTX/GTTX 	 SE
D400A 3.8	 0.1 3.3 	 0.3 1.2 	 0.1
Y401D 2.4	 0.1 5.2 	 0.3 0.5 	 0.2
Y401C 2.7 	 0.1 4.8	 0.3 0.6 	 0.1
E403Q 6.2	 0.1 5.2 	 0.3 1.2 	 0.05
E755A 5.7	 0.1 5.4 	 0.3 1.1 	 0.1
E758Q 6.0	 0.1 3.3 	 0.3 1.8 	 0.05
K1237A 3.9	 0.2 4.1 	 0.3 1.0 	 0.1
M1240E 3.9 	 0.1 4.8	 0.3 0.8 	 0.1
M1240K 6.1	 0.2 5.4 	 0.3 1.1 	 0.1
D1532N 6.2	 0.2 2.4 	 0.3 2.6 	 0.1
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Comparison of STX and TTX affinity changes
with mutation
The free energy changes for blocking efficacy (Gs) of
STX and TTX upon mutations of outer vestibule residues
are shown in Table 4. Calculation of the GSTX/GTTX
ratios for the effects of a particular mutation showed that
some mutations resulted in the identical losses in the energy
of interaction (ratio close to 1.0) and that others showed
greater affinity change for TTX (ratio  0.6) or greater
affinity change for STX (ratio  1.8).
Mutations of the three charged residues in the DEKA
selectivity region caused almost identical energy changes
for the two toxins. Glu755 showed a G of 5.4–5.7 kcal/mol
and was the most important residue for binding of either
toxin. Kontis and Goldin (1993) measured an identical G
of 4.3 kcal/mol for TTX and STX with E942Q in the brain
IIA channel isoform (the position in that isoform equivalent
to Glu755). We found that Asp400 neutralization showed a
significantly smaller G for both toxins of 3.3–3.8 kcal/
mol. The effect of substituting an Ala for Lys1237 was
3.9–4.1 kcal/mol for the toxins, although the interpretation
of this effect is unclear (see later). Similarly, Chen et al.
(1997) found that K1418C (the comparable residue in
hH1a) produced a 3.1–3.7 kcal/mol change, nearly the same
for the two toxins. The similar energies of interaction of
these three sites for TTX and STX imply that the two toxins
bind to the DEKA region of the vestibule in a nearly
identical manner. Because of the similar actions of the two
toxins and the similar interactions in this region, it seems
reasonable to propose that this represents the site of block
by both toxins.
Although STX and TTX bound in an energetically com-
parable manner to the selectivity filter region, there were
significant differences in the interaction of the toxins with
the outer ring residues. E403Q showed the same Gs for
both toxins, but both E758Q and D1532N showed much
larger Gs for the STX interactions than for those of TTX.
The larger G for E758Q agrees with the measurements of
Kontis and Goldin (1993) for the analogous brain IIA mu-
tation, E945Q. They found Gs of 3.3 kcal/mol for TTX
and 5.7 kcal/mol for STX. In addition, Terlau et al. (1991)
found double the effect of D1717N (the mutation in brain II
comparable to our D1532N) on STX blocking efficacy
compared to that of TTX (1.7 versus 3.9 kcal/mol). Fur-
thermore, for D1713C in hH1a (the location comparable to
D1532N), Chen et al. (1997) found about twice the energy
change for STX as for that of TTX with the same mutation.
One explanation might be that a functional group on STX
not available on TTX interacts at this level.
Simple electrostatic considerations appear inadequate to
explain our observations. In the most simple electrostatic
model, because STX has about twice the positive charge
that TTX does, charge-changing mutations should have had
double the effect on STX. This was not the case, however,
and elimination of charges at Asp400 and Glu755 resulted in
similar Gs for the two toxins. In addition, neutralization of
Lys1237 should have increased affinity, but on the contrary,
K1237A reduced STX and TTX affinity substantially and
nearly equally. Finally, replacement of Met1240 with either a
positive or a negative charge-reduced affinity for both tox-
ins. These results are most easily explained if the measured
Gs result from local interactions rather than through-space
electrostatic interactions with larger portions of the toxins.
Alternatively, the discussed mutations could alter the struc-
ture of the toxin binding site or the orientation of the toxins
with the site in similar ways. The fact that, of the mutations
discussed, only those of Glu755 and Lys1237 changed the
reversal potential argues against large changes in the chan-
nel conformation with the other mutations.
Rate constants offer some insight into the nature
of the toxin interactions
The Kd derived from our rate constants correlated well with
the observed equilibrium IC50 for each mutation. Our rate
constants were most similar to those measured for the frog
node of Ranvier (Ulbricht et al., 1986) but were slower than
rate constants from reconstituted skeletal muscle or brain
channels from either canines or rats (French et al., 1984;
Moczydlowski et al., 1984a,b, 1986b; Green et al., 1987;
Guo et al., 1987). These differences may be a function of the
voltage at which toxin binding was measured, of ionic
conditions, of pH, or of the presence of batrachotoxin with
the reconstituted channels. The relatively slow rate of solu-
tion change in our experiments may have affected these rate
constants, but estimates suggested that any error from this
source is not sufficient to explain the measurements, except
for the measurement of kon for the mutant Y401C. Under
these circumstances, the rate constant measurements should
be interpreted qualitatively.
Because the association rates of many small ligands are
less than expected by diffusion alone, a second rate-limiting
relaxation step of the ligand-receptor initial encounter com-
plex has been proposed (Guo et al., 1987, 1993; Escobar et
al., 1993). In our case, mutations of the outer vestibule
dramatically altered the IC50 for toxin binding but caused
small changes to the koffs. Further analysis of the changes in
rate constants was attempted using rate theory. The change
in the free energy of the transition state upon channel
mutation is a logarithmic function of the ratio of the rate
constants, assuming there are no binding intermediates with
energies lower than STX or TTX in free solution. The ratio
of the change in free energy of the transition state (G# 
RT ln[k/k]) to the change in energy of the equilibrium
bound state (G RT ln[IC50/IC50]) has been called 	 and
gives a estimate of the extent of interaction formation be-
tween a channel residue and the toxin at the transition state
(Matouschek et al., 1989; Fersht et al., 1992). This analysis
may be applied to either kon or koff, giving 	on or 	off,
respectively. If the association and dissociation pathways
follow the same reaction coordinate and a new transition
state is not created by the mutation, then 	on  1  	off.
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The basic premise is that if an association interaction occurs
early in binding, then both the energies of the transition and
the equilibrium bound states should be affected similarly by
alterations of the interaction. A more complete discussion of
this analysis may be found in Chang et al. (1998).
	off was close to 0 and 	on was 1 for all channel
mutation/toxin combinations, indicating that the transition
state energy for the dissociation reaction was not affected
greatly by the channel mutations. The kinetic analysis sug-
gested that the channel residues interacted early in the
binding reaction with both toxins and dissociated late in the
unbinding phase. In other words, the channel-toxin associ-
ations tested appeared to form before the highest energy
state during the binding reaction. Formation of the transition
and final bound states must require conformational changes
or further interactions in at least one more step, as proposed
by Guo et al. (1987).
Tyr401 is more important for TTX binding
Differences in the responses of STX and TTX to mutations
at the Tyr401 site were the most dramatic. Whereas both
toxins bound better in the presence of Tyr, the mutations
tested had a much larger impact on TTX block than on STX
block, consistent with the GSTX/GTTX ratios  1 for
Y401D and Y401C. Furthermore, STX appeared to prefer a
negative charge at this site, whereas TTX blocking efficacy
was worsened in the presence of Y401D. A possible expla-
nation for the differences in responses of STX and TTX is
that the TTX-domain I interaction has a more hydrophobic
character. Consistent with this idea, substitution of either
Gly or Ala decreases STX block by 1000 fold (Favre et
al., 1995). Alternatively, Y401D could affect binding indi-
rectly by distorting the positions of more critical channel
residues, such as Glu758 or Asp1532.
The reason why Y401C does not recapitulate the toxin
affinity seen in the heart channel is not clear. Previous
observations have suggested similar findings, and attribu-
tion of this effect to an Arg present in the heart channel one
amino acid carboxy to the domain I outer ring Glu seems to
be not entirely satisfactory (Terlau et al., 1991; Heinemann
et al., 1992a; Satin et al., 1992; Favre et al., 1995).
A new proposal for the TTX and STX
binding orientation
We speculate on the implications of these experimental
results for the toxin orientations with respect to our previ-
ously proposed model of their binding site (Lipkind and
Fozzard, 1994). The toxins seemed to bind differently at
three sites, Tyr401, Glu758, and Asp1532. Comparing the
groups most important for toxin binding (Yang and Kao,
1992), STX has two guanidinium groups (positions 1, 2, 3
and 7, 8, 9) and a C12 hydrated ketone, as compared to a
single 1,2,3 guanidinium group and a vicinal diol at the C9
and C10 sites for TTX. We attempted to dock STX and TTX
independently by assigning these different functional
groups to the channel sites showing differences in binding.
Based on the arguments of Kao and his co-workers (Yang
and Kao, 1992) about the critical nature of the STX 7,8,9
and the TTX 1,2,3 guanidinium groups for toxin activity,
these groups were reserved for interaction with the DEKA
ring. Two distinct polar interactions with Glu758 and
Asp1532 distinguished STX interactions from those of TTX.
Because D1532N had the larger effect, we located the
charged STX 1,2,3 guanidinium group at an optimal hydro-
gen bond distance from the Asp1532 side chain. This left the
C12 hydrated ketone adjacent to Glu758. After energy min-
imization, STX spanned the outer vestibule model between
domains II and IV (Fig. 2 A), and the 7,8,9 guanidinium
group (located perpendicular to the 1,2,3 guanidinium) was
in immediate contact with Glu755. The shift of the 7,8,9
guanidinium group toward domain II left a large space
between STX and Cys at position 401 (Fig. 2 B), consistent
with the accessibility of that site to a sulfhydryl reagent
(Kirsch et al., 1994) and with the minimal effect of the
Y401W mutation on STX affinity (Favre et al., 1995). The
STX carbamoyl, known to be important for binding (Stri-
chartz et al., 1995), interacted with Glu403 of domain I, and
the nonpolar C10, C11 side faced Met1240 on domain III.
With STX in this orientation, the model was able to simulate
the effects of several mutations. The calculated changes in
the interaction energies for Asp400 and Glu755 in the DEKA
ring were 4.6 and 5.6 kcal/mol, compared to measured
Gs of 3.8 and 5.6 kcal/mol, respectively. For the more
extracellular Asp1532 and Glu758, the calculated energies
were 7.4 and 6.6 kcal/mol, compared to measured Gs
of 6.2 and 6.0 kcal/mol. The calculated G for Y401C was
2.8 kcal/mol, quite similar to our experimentally observed
value of 2.7 kcal/mol.
With the TTX 1,2,3 guanidinium group located analo-
gously to the 7,8,9 guanidinium group of STX, the optimal
Tyr401/TTX interaction occurred with van der Waals con-
tacts with the nonpolar C4-C5-C7-C8 side of the toxin (Fig.
2 D). The calculated nonbonded interaction energy change
with the Y401C mutation in this location was 4.4 kcal/mol
(5.7 kcal/mol interaction with Tyr401 and 1.3 kcal/mol
with Cys401), similar to the 4.8 kcal/mol measured experi-
mentally. Moreover, the dense packing of TTX with domain
I would interfere with interaction of the sulfhydryl reagents
with a Cys in this location. This orientation of TTX resulted
in the C9 and C10 hydroxyl groups being near Glu758 and
the C11 hydroxyl group near Glu403 (Fig. 2 C). The calcu-
lated interaction energies of Asp400, Glu755, Glu758, and
Asp1532 with TTX were 3.6, 5.0, 3.6, and 2.2 kcal/
mol, consistent with the experimental findings.
The model did not reproduce all experimental findings,
however. Based on electrostatic considerations, the model
predicted that the mutation K1237A should have bound the
toxins with higher affinity because of the loss of a repulsive
force. Similarly, the model failed to predict the effect of the
M1240E mutation. Perhaps the mutations contribute in
some way to the structural integrity of the binding site, or
2654 Biophysical Journal Volume 75 December 1998
the mutations create new, less favorable orientations of the
toxins.
In summary, we performed a systematic assessment of
the effects of mutations of the outer vestibule residues
forming part of the guanidinium toxin binding site. The
charged residues in the inner selectivity region interact
similarly with STX and TTX, as demonstrated by the equiv-
alent increases in the free energies of interaction of both
toxins upon residue neutralization, supporting the conclu-
sion that the two toxins block the pore by the same mech-
anism. Two outer ring residues, Glu758 and Asp1532, were
energetically more important for STX, however, because of
the presence of the second guanidinium group. The residue
at the 401 position was confirmed as an important, but not
exclusive, contributor to the difference in guanidinium toxin
affinity between the skeletal muscle and cardiac isoforms.
FIGURE 2 Proposed orientations of STX and TTX in a model of the I Na channel outer vestibule (Lipkind and Fozzard, 1994). The P loops are formed
by 
-hairpins, and their backbones are indicated by green ribbons. (A) Orientation of STX relative to domains I–IV, as viewed from the extracellular side
down the axis of ion permeation, with the mutation Y401C present in domain I. The 1,2,3 guanidinium group is close to Asp1532 of domain IV, and the
C12 diol interacts with Glu758 of domain II. In this orientation, the carbamoyl group of STX is near Glu403. (B) Orientation of STX relative to domains
I and II, viewed in a plane parallel to the membrane, showing the interaction of the 7,8,9 guanidinium with Glu755 and Asp400. Because of its interaction
with the outer ring, STX is held away from the 401 site, leaving room for sulfhydryl reagents to react with Cys in this position in the heart isoform. (C)
Top view of the orientation of TTX with domains I–IV, showing the close packing of TTX with the domain I P loop. This packing would tend to prevent
access of sulfhydryl reagents to the 401 site. (D) Side view of the orientation of TTX relative to domains I and II. The C4-C5-C7-C8 surface of TTX is
closely packed with Tyr401. Carbon, nitrogen, oxygen, and hydrogen are green, blue, red, and white, respectively.
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Distinctions in the response of toxins to mutations at the 401
site were noted, and modeling suggested that TTX might
have a more intimate nonbonded interaction with domain I
than STX, protecting this site from modification by sulfhy-
dryl reagents. Our revised model was able to simulate the
energies of interaction with six of the eight residues studied.
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